Related Experiment Videos
Bone scanning in patients with pleural effusion--experience in 76 cases
S Kosuda1, K Yokoyama, I Nishiguchi
1Department of Radiology, Tokyo Metropolitan Komagome Hospital, Japan.
Annals of Nuclear Medicine
|July 1, 1990
Summary
This study investigated technetium-99m-labeled methylene diphosphonate (99mTc-MDP) accumulation in pleural effusions. Results show passive transudation is the primary mechanism for 99mTc-MDP buildup in the chest.
Area of Science:
- Nuclear medicine
- Radiopharmaceuticals
- Thoracic medicine
Background:
- Pleural effusion diagnosis and management present clinical challenges.
- Understanding radiopharmaceutical behavior in pleural effusions is crucial for diagnostic accuracy.
Purpose of the Study:
- To determine the incidence of 99mTc-MDP accumulation in patients with pleural effusion.
- To elucidate the underlying mechanism of 99mTc-MDP accumulation in the hemithorax.
Main Methods:
- Seventy-six patients with malignant or benign pleural effusion were included.
- Incidence of diffuse 99mTc-MDP uptake in the hemithorax was assessed.
- Correlation between effusion volume and radiotracer accumulation was analyzed.
Main Results:
- 61% of patients exhibited diffuse 99mTc-MDP uptake in the hemithorax.
- Positive uptake rates were similar for malignant (62%) and benign (57%) effusions.
- Accumulation showed a positive correlation with increasing effusion volume.
Conclusions:
- 99mTc-MDP accumulation is a common finding in pleural effusions.
- Passive transudation is identified as the principal mechanism for unilateral intrathoracic 99mTc-MDP accumulation.
- Findings support the role of passive fluid dynamics in radiotracer distribution within the pleural space.